Cure My Disease

Don't miss your cure!

 Log in / Sign up

Nerve block could cut opioid need after hip fracture surgery

NCT ID NCT07716540

Symptom relief Sponsor: Kanuni Sultan Suleyman Training and Research Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 21, 2026 · Last updated Jul 31, 2026 · Updated 3 times

Summary

This study tests whether a specific nerve block, called the deep iliacus plane block, can reduce the amount of opioid pain medication needed after hip fracture surgery. Half of the participants receive the real block with bupivacaine, while the other half receive a sham (fake) block. The goal is to see if this approach leads to less pain and fewer opioid-related side effects.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
an ultrasound-guided deep iliacus plane block using bupivacaine
What this could lead to
If effective, this nerve block could reduce the need for opioid painkillers after hip fracture surgery, leading to faster recovery and fewer side effects.
What could go wrong
This is a small, early-stage trial with only 52 participants, so results may not apply to all patients. The block may not provide significant pain relief over standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 52 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jul 2026

An estimate. Start dates often move.

Expected to finish

Jan 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 18 years or older * Scheduled to undergo unilateral hip fracture surgery under spinal anesthesia * American Society of Anesthesiologists (ASA) physical status I-III * Ability to understand and use the Numerical Rating Scale and patient-controlled analgesia device * No contraindication to spinal anesthesia or the deep iliacus plane block * Written informed consent provided by the participant or legally authorized representative Exclusion Criteria: * ASA physical status IV or higher * Emergency surgery * Coagulopathy, bleeding diathesis, or anticoagulant treatment that contraindicates spinal anesthesia or peripheral nerve block * Infection at the planned needle insertion site * Known allergy to local anesthetics or any study medication * Pre-existing peripheral neuropathy, neurological disorder, or motor deficit involving the operated lower extremity * Inability to understand or use the Numerical Rating Scale or patient-controlled analgesia device * Cognitive impairment or communication difficulty preventing reliable postoperative assessment * Refusal to participate

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hip fracture are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

agnosia hip fracture

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Pain management

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Health Science University İstanbul Kanuni Sultan Süleyman Education and Training Hospital

    RECRUITING

    Istanbul, Istanbul, 34303, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.